Mirae Asset Global Investments Co. Ltd. Sells 15,675 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Mirae Asset Global Investments Co. Ltd. lowered its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 14.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 90,238 shares of the company’s stock after selling 15,675 shares during the period. Mirae Asset Global Investments Co. Ltd. owned 0.08% of Definitive Healthcare worth $897,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the business. Vanguard Group Inc. increased its position in Definitive Healthcare by 6.2% during the third quarter. Vanguard Group Inc. now owns 4,331,543 shares of the company’s stock valued at $34,609,000 after acquiring an additional 254,726 shares during the last quarter. Raymond James & Associates lifted its position in shares of Definitive Healthcare by 24.2% during the third quarter. Raymond James & Associates now owns 650,327 shares of the company’s stock valued at $5,196,000 after buying an additional 126,613 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of Definitive Healthcare by 11.7% during the third quarter. Bank of New York Mellon Corp now owns 1,090,136 shares of the company’s stock valued at $8,710,000 after buying an additional 113,963 shares during the last quarter. Envestnet Asset Management Inc. lifted its position in shares of Definitive Healthcare by 41.7% during the third quarter. Envestnet Asset Management Inc. now owns 383,151 shares of the company’s stock valued at $3,061,000 after buying an additional 112,718 shares during the last quarter. Finally, Victory Capital Management Inc. raised its position in shares of Definitive Healthcare by 68.4% in the 3rd quarter. Victory Capital Management Inc. now owns 269,433 shares of the company’s stock valued at $2,153,000 after purchasing an additional 109,463 shares during the last quarter. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Trading Down 0.8 %

Shares of NASDAQ:DH opened at $7.27 on Wednesday. Definitive Healthcare Corp. has a 52 week low of $5.53 and a 52 week high of $12.45. The company’s 50 day moving average is $8.28 and its two-hundred day moving average is $8.31. The company has a current ratio of 2.31, a quick ratio of 2.31 and a debt-to-equity ratio of 0.20. The company has a market cap of $856.33 million, a PE ratio of -4.08, a P/E/G ratio of 6.15 and a beta of 1.39.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a negative net margin of 80.40% and a positive return on equity of 0.43%. The firm had revenue of $65.93 million during the quarter, compared to analysts’ expectations of $66.01 million. Equities analysts predict that Definitive Healthcare Corp. will post 0.11 earnings per share for the current fiscal year.

Analyst Ratings Changes

DH has been the topic of several research reports. Canaccord Genuity Group increased their price target on shares of Definitive Healthcare from $9.00 to $10.00 and gave the stock a “hold” rating in a report on Thursday, February 29th. Stifel Nicolaus reduced their price target on Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating on the stock in a report on Wednesday, January 17th. Barclays raised their price objective on Definitive Healthcare from $10.00 to $11.00 and gave the stock an “equal weight” rating in a research report on Friday, March 1st. Canaccord Genuity Group downgraded Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Finally, Needham & Company LLC cut shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, January 17th. Seven equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $11.31.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.